These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29534895)

  • 1. In Vitro and In Vivo Characterization of a Preclinical Irradiation-Adapted Model for Ewing Sarcoma.
    Shapiro MC; Tang T; Dasgupta A; Kurenbekova L; Shuck R; Gaber MW; Yustein JT
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):118-127. PubMed ID: 29534895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on
    Inagaki C; Shimoi T; Sumiyoshi Okuma H; Kawachi A; Sudo K; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Arakawa A; Ogawa C; Yoshida A; Fujiwara Y; Tamura K
    Med Oncol; 2019 May; 36(7):58. PubMed ID: 31104192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
    Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA
    AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of therapeutic targets in Ewing sarcoma family tumors.
    Ahmed AA; Sherman AK; Pawel BR
    Hum Pathol; 2012 Jul; 43(7):1077-83. PubMed ID: 22196127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy.
    Ma WW; Jacene H; Song D; Vilardell F; Messersmith WA; Laheru D; Wahl R; Endres C; Jimeno A; Pomper MG; Hidalgo M
    J Clin Oncol; 2009 Jun; 27(16):2697-704. PubMed ID: 19380450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma?
    Andreani L; Ipponi E; Ruinato AD; Lupi T; Di Sacco F; Volterrani D; Coccoli L; Capanna R
    Folia Med (Plovdiv); 2024 Apr; 66(2):196-202. PubMed ID: 38690814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.
    Raciborska A; Bilska K; Drabko K; Michalak E; Chaber R; Pogorzała M; Połczyńska K; Sobol G; Wieczorek M; Muszyńska-Rosłan K; Rychlowska-Pruszyńska M; Rodriguez-Galindo C; Dziuk M
    Clin Transl Oncol; 2016 Feb; 18(2):189-95. PubMed ID: 26250765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012.
    Johnsen B; Fasmer KE; Boye K; Rosendahl K; Trovik C; Biermann M; Aukland SM
    Pediatr Radiol; 2017 Jan; 47(1):82-88. PubMed ID: 27815616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
    O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
    Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.
    Hong SH; Tilan JU; Galli S; Izycka-Swieszewska E; Polk T; Horton M; Mahajan A; Christian D; Jenkins S; Acree R; Connors K; Ledo P; Lu C; Lee YC; Rodriguez O; Toretsky JA; Albanese C; Kitlinska J
    Oncotarget; 2015 Mar; 6(9):7151-65. PubMed ID: 25714031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different.
    Gaston LL; Di Bella C; Slavin J; Hicks RJ; Choong PF
    Skeletal Radiol; 2011 Aug; 40(8):1007-15. PubMed ID: 21298431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.
    Newman EN; Jones RL; Hawkins DS
    Pediatr Blood Cancer; 2013 Jul; 60(7):1113-7. PubMed ID: 23192939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway.
    Lagares-Tena L; García-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Huertas-Martínez J; Sáinz-Jaspeado M; Mateo-Lozano S; Rodríguez-Galindo C; Rello-Varona S; Herrero-Martín D; Tirado OM
    Oncotarget; 2016 Aug; 7(35):56889-56903. PubMed ID: 27487136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging and follow-up of a Ewing sarcoma patient using
    Garcia JR; Castañeda A; Morales La Madrid A; Bassa P; Soler M; Riera E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):387-389. PubMed ID: 29107752
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
    Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
    J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
    Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC
    Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure.
    Rübe CE; van Valen F; Wilfert F; Palm J; Schuck A; Willich N; Winkelmann W; Jürgens H; Rübe C
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1414-25. PubMed ID: 12873688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma.
    Ruggiero A; Lanni V; Librizzi A; Maurizi P; Attinà G; Mastrangelo S; Giordano A; Riccardi R
    J Pediatr Hematol Oncol; 2018 May; 40(4):277-284. PubMed ID: 29620679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells.
    Passacantilli I; Frisone P; De Paola E; Fidaleo M; Paronetto MP
    Nucleic Acids Res; 2017 Dec; 45(21):12270-12284. PubMed ID: 29036465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
    Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.